Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

Market Cap	8.40B +8.0%
Revenue (ttm)	1.29B +1.2%
Net Income	275.24M -16.3%
EPS	0.46 -19.3%
Shares Out	544.82M
PE Ratio	33.37
Forward PE	n/a
Dividend	0.11 (0.73%)
Ex-Dividend Date	May 27, 2026

Volume	14,893,856
Open	16.61
Previous Close	15.33
Day's Range	15.29 - 16.61
52-Week Range	10.68 - 23.44
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 20, 2026

About SHE:300401

Zhejiang Garden Biopharmaceutical Co.,Ltd. engages in the research, development, production and sales of vitamin products and pharmaceuticals in China. The company offers lanolin cholesterol series products, such as cholesterol and feed grade cholesterol; vitamin D3 products, including food additives compound nutrient fortifier SDS, food additives compound nutritional fortifier CO and MO, cholecalciferol, vitamin D3 particles, feed additive vitamin D3 oil, and VD3 resin oil; and 25 HydroxyVitamin D3 Progen, 25 hydroxyvitamin D3, and 25 hydroxyv...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 1,163
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300401

Financial Performance

In 2025, SHE:300401's revenue was 1.24 billion, a decrease of -0.47% compared to the previous year's 1.24 billion. Earnings were 304.86 million, a decrease of -1.41%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error